Pharma skirmish looms in US Presidential race
The pharmaceutical industry looks set to be one of the key areas of contention for the two US Presidential candidates as they square off ahead of the election in November.
Archives for March 28, 2004
EU aims to tackle growing TB problem
The European Commission has announced a collaborative tuberculosis research initiative, underpinned by €32 million in funding for two overlapping research projects aimed at developing an improved vaccine for the disease. The news came in the wake of...
New technique simplifies NA analysis
An application that will enable direct measurement of nucleic acids without the need for amplification has been developed by US Genomics. The application will also allow researchers to perform validation and characterization of specific microRNAs...
Vascular-targetting cancer drug clears Phase I
Germany's Munich Biotech has reported encouraging data on a new cancer treatment that takes a tried and tested drug and improves its safety and efficacy, according to preliminary trial results.
Benitec gets legal over RNAi
Benitec, the Australian biotechnology firm, has launched patent infringement suits in a US district court against Nucleonics, Ambion, and Genscript, alleging that the three companies are infringing a US patent concerning gene silencing technologies,...
US changes label requirements for OTCs
The US Food and Drug Administration (FDA) has created a new rule requiring content and warning labelling for over-the-counter (OTC) drugs that contain levels of calcium, magnesium, sodium, or potassium that might be harmful to people with certain...
ProSolv cleared for marketing in Japan
The Japanese regulatory authority has approved the JRS Pharma's ProSolv excipient - designed to make it easier and cheaper to make high-quality tablets - for use in pharmaceutical formulations.
TOTAL at the pharma and food interface
The first ever TOTAL Processing and Packaging Show opens its doors this week, bringing together tens of thousands of processing and packaging professionals across the pharmaceutical and food sectors and providing a rare opportunity for the two...